why choose us

First received: May 28, 2024

Clinical Trial: An Observational Study to Assess Optive MEGA-3 (OM3) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Dry Eye

Study Type: OBSERVATIONAL


Official Title: Patient Experience Study Evaluating Effect of OM3 on Dry Eye Symptoms and Quality of Life in Patients With Mild to Moderate Dry Eye Disease

Brief Summary: Dry Eye Disease (DED) is a condition where the tear film of the eye becomes unstable and along with ocular surface inflammation and damage leads to inadequate tear production and eye lubrication.This study will evaluate real-world experiences with Optive MEGA-3 (OM3) on relieving dry eye symptoms in adult participants with DED.OM3 is an over the counter (OTC) monograph drug indicated for the temporary relief of symptoms of eye dryness.Participants will administer 1 drop of OM3 on Day 1 for the acute phase of the…

Read more